Onco-Innovations Limited
ONCO
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -66.67% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -66.67% | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -66.67% | -- | -- | -- | |
| SG&A Expenses | -24.73% | 54.63% | 1,948.26% | 340.97% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -8.39% | 64.71% | 1,848.08% | 449.26% | |
| Operating Income | 5.34% | -64.71% | -1,806.09% | -436.19% | |
| Income Before Tax | 67.27% | -34.05% | -1,862.67% | -734.10% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 67.27% | -34.05% | -1,862.67% | -734.10% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 67.27% | -34.05% | -1,862.67% | -734.10% | |
| EBIT | 5.34% | -64.71% | -1,806.09% | -436.19% | |
| EBITDA | -- | -- | -- | -- | |
| EPS Basic | 72.70% | 5.94% | -1,268.57% | -433.33% | |
| Normalized Basic EPS | 33.53% | 6.77% | -1,259.09% | -945.45% | |
| EPS Diluted | 72.70% | 5.94% | -1,268.57% | -433.33% | |
| Normalized Diluted EPS | 33.53% | 6.77% | -1,259.09% | -945.45% | |
| Average Basic Shares Outstanding | 19.61% | 42.39% | 41.54% | 56.27% | |
| Average Diluted Shares Outstanding | 19.61% | 42.39% | 41.54% | 56.27% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |